Literature DB >> 20585233

Effect of mesenchymal stem cells on skin graft to flap prefabrication: an experimental study.

Cagri A Uysal1, Rei Ogawa, Feng Lu, Hiko Hyakusoku, Hiroshi Mizuno.   

Abstract

Angiogenetic potential has been reported for bone marrow-derived stem cells (BSCs) and adipose-derived stem cells (ASCs). The superficial femoral artery, vein, and fascia were used as a vascular crane for prefabrication model of skin graft to flap. BSCs or ASCs were injected before the adaptation of the graft to the vascular crane depending on the group. The prefabricated grafts were then transferred to inguinal region in every 7 days to observe the viability. In experiment part I (n = 18), the critical time for the prefabrication was found to be 1 week. In experiment part II (n = 12), the control and experiment assays were performed on the same animal to support the data of the experiment part I. The viability of flaps was evaluated. The vascular density was higher in BSC, and ASC groups. The Vascular Endothelial Growth Factor immunohistochemical staining was quantified. Furthermore, mesenchymal stem cells could be helpful in any prefabrication procedure in which neovascularization is indispensable.

Entities:  

Mesh:

Year:  2010        PMID: 20585233     DOI: 10.1097/SAP.0b013e3181c1ff14

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  10 in total

1.  Fibrin-embedded adipose derived stem cells enhance skin flap survival.

Authors:  Matthias A Reichenberger; Wolf Mueller; Amelia Schäfer; Sina Heimer; Uwe Leimer; Ulrike Lass; Günter Germann; Eva Köllensperger
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

Review 2.  Role of adipose-derived stromal cells in pedicle skin flap survival in experimental animal models.

Authors:  Pericles Foroglou; Vasileios Karathanasis; Efterpi Demiri; George Koliakos; Marios Papadakis
Journal:  World J Stem Cells       Date:  2016-03-26       Impact factor: 5.326

3.  Adipose derived stem cells protect skin flaps against ischemia-reperfusion injury.

Authors:  Matthias A Reichenberger; Sina Heimer; Amelia Schaefer; Ulrike Lass; Martha Maria Gebhard; Günter Germann; Uwe Leimer; Eva Köllensperger; Wolf Mueller
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

4.  Coactivity of Mast Cells and Stem Cells on Angiogenesis and Antioxidants' Potentials at Inflammation, Proliferation, and Tissue Remodeling Phases of Wound.

Authors:  Mahshad Mousavi; Ahmad Khanifar; Nazanin Mousavi; Khatereh Anbari; Farzaneh Chehelcheraghi
Journal:  Arch Plast Surg       Date:  2022-05-27

5.  Effect of the PI3K/AKT signaling pathway on hypoxia-induced proliferation and differentiation of bone marrow-derived mesenchymal stem cells.

Authors:  Lingling Sheng; Xiyuan Mao; Qingxiong Yu; Dong Yu
Journal:  Exp Ther Med       Date:  2016-11-18       Impact factor: 2.447

6.  Skin Mast Cell Promotion in Random Skin Flaps in Rats using Bone Marrow Mesenchymal Stem Cells and Amniotic Membrane

Authors:  Farzaneh Chehelcheraghi; Abolfazl Abbaszadeh; Magid Tavafi
Journal:  Iran Biomed J       Date:  2018-03-06

Review 7.  Preclinical efficacy of stem cell therapy for skin flap: a systematic review and meta-analysis.

Authors:  Yuan Li; Qi-Lin Jiang; Leanne Van der Merwe; Dong-Hao Lou; Cai Lin
Journal:  Stem Cell Res Ther       Date:  2021-01-07       Impact factor: 6.832

Review 8.  Stem cell therapy for lower extremity diabetic ulcers: where do we stand?

Authors:  Mei Yang; Lingling Sheng; Tian R Zhang; Qingfeng Li
Journal:  Biomed Res Int       Date:  2013-03-18       Impact factor: 3.411

9.  A novel animal model for skin flap prelamination with biomaterials.

Authors:  Xianyu Zhou; Xusong Luo; Fei Liu; Chuan Gu; Xi Wang; Qun Yang; Yunliang Qian; Jun Yang
Journal:  Sci Rep       Date:  2016-09-23       Impact factor: 4.379

10.  Efficacy of Cellular Therapy for Diabetic Foot Ulcer: A Meta-Analysis of Randomized Controlled Clinical Trials.

Authors:  Ye Zhang; Hong Deng; Zhouping Tang
Journal:  Cell Transplant       Date:  2017-12       Impact factor: 4.064

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.